Thomas; Andrew Peter
Patent Applications and Registrations
Patent applications and USPTO patent grants for Thomas; Andrew Peter.The latest application filed is for "quinazoline derivatives as vegf inhibitors".
Company Profile
3.40.41
- Thomas; Andrew Peter - Cheshire GB
- Thomas; Andrew Peter - Cambridge GB
- THOMAS; Andrew Peter - Macclesfield GB
- Thomas; Andrew Peter - Macclesfield Cheshire GB
- Thomas, Andrew Peter - Alderley Park Macclesfield Cheshire GB
- Thomas; Andrew Peter - Congleton GB
Patent Activity
| Patent | Date |
|---|---|
| Quinazoline Derivatives as VEGF Inhibitors App 20210276972 - Thomas; Andrew Peter ; et al. | 2021-09-09 |
| Quinazoline Derivatives as VEGF Inhibitors App 20200262811 - Thomas; Andrew Peter ; et al. | 2020-08-20 |
| Quinazoline derivatives as VEGF inhibitors Grant 10,457,664 - Thomas , et al. Oc | 2019-10-29 |
| Compounds Grant 10,301,267 - Buttar , et al. | 2019-05-28 |
| Quinazoline Derivatives as VEGF Inhibitors App 20190002433 - Thomas; Andrew Peter ; et al. | 2019-01-03 |
| Quinazoline Derivatives as VEGF Inhibitors App 20180099946 - Thomas; Andrew Peter ; et al. | 2018-04-12 |
| Novel Compounds App 20170260143 - BUTTAR; David ; et al. | 2017-09-14 |
| Methods of treating cancer with a pyrazole derivative Grant 9,688,640 - Buttar , et al. June 27, 2 | 2017-06-27 |
| Quinazoline Derivatives as VEGF Inhibitors App 20160130249 - Thomas; Andrew Peter ; et al. | 2016-05-12 |
| Novel Compounds App 20150299134 - BUTTAR; David ; et al. | 2015-10-22 |
| Quinazoline derivatives as VEGF inhibitors Grant 9,040,548 - Thomas , et al. May 26, 2 | 2015-05-26 |
| Quinazoline Derivatives as VEGF Inhibitors App 20140121228 - Thomas; Andrew Peter ; et al. | 2014-05-01 |
| Novel Compounds App 20140066455 - BUTTAR; David ; et al. | 2014-03-06 |
| Quinazoline derivatives as VEGF inhibitors Grant 8,642,608 - Thomas , et al. February 4, 2 | 2014-02-04 |
| N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpipera- zin-1-yl)benzamide and salts thereof Grant 8,604,022 - Foote , et al. December 10, 2 | 2013-12-10 |
| N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpipera- Zin-1-yl)benzamide And Salts Thereof App 20120129844 - Buttar; David ; et al. | 2012-05-24 |
| N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(3,4-dimethylpipera- zin-1-yl)benzamide and salts thereof Grant 8,129,391 - Foote , et al. March 6, 2 | 2012-03-06 |
| Quinazoline derivatives and pharmaceutical compositions containing them Grant RE42,353 - Thomas , et al. May 10, 2 | 2011-05-10 |
| Quinazoline Derivatives And Pharmaceutical Compositions Containing Them App 20110071144 - THOMAS; Andrew Peter ; et al. | 2011-03-24 |
| Quinazoline Derivatives As Vegf Inhibitors App 20110065736 - Thomas; Andrew Peter ; et al. | 2011-03-17 |
| N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(3,4-dimethylpipera- zin-1-yl)benzamide and Salts Thereof App 20100273811 - Buttar; David ; et al. | 2010-10-28 |
| N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpipera- zin-1-yl)benzamide and salts thereof Grant 7,737,149 - Buttar , et al. June 15, 2 | 2010-06-15 |
| Pyrazole Compounds 436 App 20090318468 - Buttar; David ; et al. | 2009-12-24 |
| Pyrimidine Derivatives For The Inhibition Of Igf-ir Tyrosine Kinase Activity App 20090306116 - Thomas; Andrew Peter ; et al. | 2009-12-10 |
| Pyrimidine derivatives possessing cell-cycle inhibitors activity Grant 7,579,344 - Heaton , et al. August 25, 2 | 2009-08-25 |
| 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer Grant 7,579,349 - Nowak , et al. August 25, 2 | 2009-08-25 |
| Pyrimidine compounds Grant 7,485,638 - Newcombe , et al. February 3, 2 | 2009-02-03 |
| Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity Grant 7,465,728 - Newcombe , et al. December 16, 2 | 2008-12-16 |
| Pyrimidine compounds Grant 7,446,105 - Newcombe , et al. November 4, 2 | 2008-11-04 |
| Novel Compounds 747 App 20080269266 - Nowak; Thorsten ; et al. | 2008-10-30 |
| 4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity Grant 7,442,697 - Newcombe , et al. October 28, 2 | 2008-10-28 |
| 2-Anilino-4-(imidazol-5-yl)-pyrimidine derivatives and their use as cdk (cdk2) inhibitors Grant 7,427,626 - Thomas September 23, 2 | 2008-09-23 |
| 4-(Pyrid-2-Yl) Amino Substituted Pyrimidine as Protein Kinase Inhibitors App 20080171742 - Thomas; Andrew Peter ; et al. | 2008-07-17 |
| Pyrimidine Derivatives for Use as Anticancer Agents App 20080167297 - Thomas; Andrew Peter ; et al. | 2008-07-10 |
| 2-Azetidinyl-4-(1H-Pyrazol-3-Ylamino) Pyrimidines as Inhibitors of Insulin-Like Growth Factor-1 Receptor Activity App 20080161278 - Thomas; Andrew Peter ; et al. | 2008-07-03 |
| Pyrimidines as Igf-I Inhibitors App 20080161330 - Thomas; Andrew Peter | 2008-07-03 |
| Novel Compounds App 20080153812 - Buttar; David ; et al. | 2008-06-26 |
| Novel Compounds App 20080004302 - Theoclitou; Maria-Elena ; et al. | 2008-01-03 |
| Quinazoline derivatives as VEGF inhibitors App 20070265286 - Thomas; Andrew Peter ; et al. | 2007-11-15 |
| 2-Anilino-4-(imidazol-5-yl)-pyrimidine derivatives and their use as cdk(cdk2) inhibitors App 20070037839 - Thomas; Andrew Peter | 2007-02-15 |
| 4-(Pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer App 20070037888 - Nowak; Thorsten ; et al. | 2007-02-15 |
| Quinazoline derivatives as VEGF inhibitors Grant 7,173,038 - Thomas , et al. February 6, 2 | 2007-02-06 |
| Pyrimidine derivatives possessing cell-cycle inhibitors activity App 20060229329 - Heaton; William David ; et al. | 2006-10-12 |
| Cinnoline derivatives and use as medicine Grant 7,087,602 - Thomas , et al. August 8, 2 | 2006-08-08 |
| 4-Imidazolyl substituted pyrimidine derivatives with cdk inhibitory activity App 20060074096 - Newcombe; Nicholas John ; et al. | 2006-04-06 |
| Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation App 20060004033 - Breault; Gloria Anne ; et al. | 2006-01-05 |
| Imidazolo-5-YL-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation Grant 6,969,714 - Breault , et al. November 29, 2 | 2005-11-29 |
| Pyrimidine compounds App 20050256311 - Newcombe, Nicholas John ; et al. | 2005-11-17 |
| Quinazoline derivatives and pharmaceutical compositions containing them App 20050239777 - Thomas, Andrew Peter ; et al. | 2005-10-27 |
| 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors Grant 6,939,872 - Newcombe , et al. September 6, 2 | 2005-09-06 |
| Pyrimidine derivatives Grant 6,908,920 - Thomas , et al. June 21, 2 | 2005-06-21 |
| Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity App 20050131000 - Newcombe, Nicholas John ; et al. | 2005-06-16 |
| 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases Grant 6,906,065 - Thomas June 14, 2 | 2005-06-14 |
| Pyrimidine compounds App 20050119291 - Newcombe, Nicholas John ; et al. | 2005-06-02 |
| Quinazoline derivatives and pharmaceutical compositions containing them Grant 6,897,210 - Thomas , et al. May 24, 2 | 2005-05-24 |
| Imidazo[1,2-A]pyridine and pyrazolo[2,3-A]pyridine derivatives Grant 6,855,719 - Thomas , et al. February 15, 2 | 2005-02-15 |
| Pyrimidine derivatives for inhibition of cell proliferation Grant 6,844,341 - Thomas January 18, 2 | 2005-01-18 |
| Quinazoline Derivatives And Pharmaceutical Compositions Containing Them App 20040242574 - Thomas, Andrew Peter ; et al. | 2004-12-02 |
| Quinoline derivatives inhibiting the effect of growth factors such as VEGF Grant 6,809,097 - Thomas , et al. October 26, 2 | 2004-10-26 |
| 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors App 20040198757 - Newcombe, Nicholas John ; et al. | 2004-10-07 |
| Pyrimidine derivatives for inhibition of cell proliferation App 20040097506 - Thomas, Andrew Peter | 2004-05-20 |
| Imidazolo-5-YL-2anilino-pyrimidines as agents for the inhibition of the cell proliffration App 20040014776 - Breault, Gloria Anne ; et al. | 2004-01-22 |
| Quinazoline derivatives and pharmaceutical compositions containing them Grant 6,673,803 - Thomas , et al. January 6, 2 | 2004-01-06 |
| Pyrimidine derivatives App 20030216406 - Thomas, Andrew Peter ; et al. | 2003-11-20 |
| Cinnoline derivatives and use as medicine App 20030199513 - Thomas, Andrew Peter ; et al. | 2003-10-23 |
| 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases App 20030087923 - Thomas, Andrew Peter | 2003-05-08 |
| Cinnoline derivatives and use as medicine Grant 6,514,971 - Thomas , et al. February 4, 2 | 2003-02-04 |
| Quinazoline derivatives and pharmaceutical compositions containing them App 20020173646 - Thomas, Andrew Peter ; et al. | 2002-11-21 |
| Quinazoline derivatives and pharmaceutical compositions containing them Grant 6,414,148 - Thomas , et al. July 2, 2 | 2002-07-02 |
| Chemical compounds Grant 6,362,336 - Lohmann , et al. March 26, 2 | 2002-03-26 |
| Chemical compounds App 20020032208 - Lohmann, Jean-Jacques Marcel ; et al. | 2002-03-14 |
| Oxindolylquinazoline derivatives as angiogenesis inhibitors Grant 6,294,532 - Thomas , et al. September 25, 2 | 2001-09-25 |
| 4-anilinoquinazoline derivatives Grant 6,291,455 - Thomas , et al. September 18, 2 | 2001-09-18 |
| Oxindole derivatives Grant 6,265,411 - Thomas , et al. July 24, 2 | 2001-07-24 |
| Chemical compounds Grant 6,258,951 - Lohmann , et al. July 10, 2 | 2001-07-10 |
| Quinazoline derivatives as VEGF inhibitors Grant 6,184,225 - Thomas , et al. February 6, 2 | 2001-02-06 |
| Chemical compounds Grant 6,071,921 - Lohmann , et al. June 6, 2 | 2000-06-06 |
| Substituted quinazolines Grant 5,962,458 - Lohmann , et al. October 5, 1 | 1999-10-05 |
| Aniline derivatives Grant 5,821,246 - Brown , et al. October 13, 1 | 1998-10-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 